Home > Share Market > Stocks > Transgene Biotek Ltd > Financial Statements > Cash Flow

Transgene Biotek Ltd Financial Statements

Transgene Biotek Ltd Cash Flow Statement

  • Tabular Data
  • Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax (10) (11) (5.70) (20)
Depreciation (9.90) (9.90) (9.90) (18)
Tax paid -- -- (0.80) --
Working capital (33) (4.20) (9.20) (1.90)
Other operating items -- -- -- --
Operating cashflow (53) (25) (26) (39)
Capital expenditure (7.30) (8.60) (102) (101)
Free cash flow (61) (34) (127) (140)
Equity raised 167 223 249 133
Investments -- -- -- --
Debt financing/disposal 3.97 18.30 20.40 17.20
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 110 208 143 10.50

OPEN A DEMAT ACCOUNT & Get
FREE Benefits worth 10,000